Pol Stanislas
Unité d'hépatologie et Inserm U-370, Hôpital Necker, Paris.
Presse Med. 2006 Feb;35(2 Pt 2):308-16. doi: 10.1016/s0755-4982(06)74576-6.
Hepatitis B virus (HBV) is transmitted by parenteral, sexual and perinatal routes. While fulminant hepatitis may occur in 1% of cases of symptomatic acute hepatitis, the principal problem of HBV infection is that it may become chronic, classically defined by carriage of HB surface antigens (HBsAg) for more than 6 months. This occurs in only 0.5 to 3% of immunocompetent adults but more frequently in children (up to 90%) and in immune-compromised patients (30 to 100%). The course of chronic HBV infection is characterized by variations in viral replication with spontaneous reactivation or discontinuation, and potential exacerbations observed clinically or by laboratory testing. The pathogenesis of HBV infection is mainly immune-mediated, resulting from host-virus interactions but also from the complexity of the virus itself (integration, mutation, occult replication). These factors explain the variety of presentations of chronic HBV infection, which range from immune tolerance to inactive carriage of HBsAg, passing through a stage of immune clearance, where chronic active hepatitis which may lead to cirrhosis (yearly incidence of 1.3 to 5.9%). Cirrhosis may be complicated by portal hypertension, liver failure, or hepatocellular carcinoma, which together explain 80% of the morbidity and mortality associated with HBV. The 5-year survival rate for HBV-related cirrhosis ranges from 52 to 82%. Immunosuppression, hepatitis D virus superinfection, and chronic alcohol consumption are the principal factors that modify this natural history. Chronic HBV infection is a major public health problem, particularly in developing countries, and it requires that efforts to make HBV vaccination universal be intensified.
乙型肝炎病毒(HBV)通过肠道外、性接触和围产期途径传播。虽然暴发性肝炎可能发生在1%的有症状急性肝炎病例中,但HBV感染的主要问题是它可能会变成慢性,传统上定义为HB表面抗原(HBsAg)携带超过6个月。这种情况仅发生在0.5%至3%的免疫功能正常的成年人中,但在儿童中更常见(高达90%),在免疫功能低下的患者中也更常见(30%至100%)。慢性HBV感染的病程特点是病毒复制有变化,可自发重新激活或停止,临床上或实验室检测可观察到潜在的病情加重。HBV感染的发病机制主要是免疫介导的,由宿主-病毒相互作用引起,但也源于病毒本身的复杂性(整合、突变、隐匿复制)。这些因素解释了慢性HBV感染的多种表现形式,从免疫耐受到HBsAg的非活动性携带,经过免疫清除阶段,在此阶段可能会出现慢性活动性肝炎,进而可能导致肝硬化(年发病率为1.3%至5.9%)。肝硬化可能并发门静脉高压、肝衰竭或肝细胞癌,这些共同解释了与HBV相关的80%的发病率和死亡率。HBV相关肝硬化的5年生存率在52%至82%之间。免疫抑制、丁型肝炎病毒重叠感染和长期饮酒是改变这种自然病程的主要因素。慢性HBV感染是一个主要的公共卫生问题,特别是在发展中国家,需要加大力度普及HBV疫苗接种。